Overview (04 Nov 2026)
Alivus Life Sciences Ltd
ALIVUS
INE03Q201024
Pharmaceuticals
40.7
Prev. Close
Previous Close
1480.2
Current Close
1520.9
Current High
1526.8
Current Low
1465
52 Week High
1526.8
52 Week Low
830
Resistance 1
1543.46
Resistance 2
1566.03
Support 1
1481.66
Support 2
1419.86
Std Deviation
4.14%
DMA 200
1130.40
DMA 50
1368.78
DMA 20
1350.25
Fundamentals and Ratios
Standalone
Trailing EPS
45.99
Forwad EPS
56.39
Trailing P/E
33.07
Forward P/E
26.97
PEG Ratio
Mkt. Cap (Cr)
Market Cap (Cr)
18667.44
Total Debt(Cr)
Tot. Debt(Cr)
NA
Reserve (Cr)
NA
Book Value
NA
P/BV Ratio
NA
ROCE(%)
N/A
ROE
N/A

 

Financial Result
Standalone
TypeSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue681.99640.41689.12672.89587.982551.83
Other Income19.9222.4022.7813.9314.7260.41
Total Income701.90662.82711.90686.82602.702612.24
Interest1.311.311.311.491.325.37
Expenditure-439.93-450.59-496.10-462.77-428.56-1835.28
PBDT0.000.000.000.000.000.00
Depreciation-21.82-20.59-20.20-19.66-18.44-75.36
PBT261.97212.22215.80198.39174.14751.31
Tax-65.23-52.15-53.14-48.13-44.11-186.83
Equity24.5524.5524.5524.540.0024.55
OPM37.3232.0230.3128.8929.6228.76
Net Profit196.75160.08162.66150.26130.03564.48
NPM28.0324.1522.8521.8822.1121.61
EPS16.0213.0413.2312.2510.645.99
Consolidated
TypeFY25-26
Revenue2551.83
Other Income60.41
Total Income2612.24
Interest5.37
Expenditure-1835.28
PBDT0.00
Depreciation-75.36
PBT751.31
Tax-186.83
Equity24.55
OPM28.76
Net Profit564.48
NPM21.61
EPS45.99
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2026Final Dividend5.00Final Dividend - Rs. - 5.000001 Sep 2026
2025Final Dividend5.00Final Dividend - Rs. - 5.000001 Sep 2025
2024Interim Divvidend22.50Interim Dividend - Rs. - 22.500017 Oct 2023
2023Interim Divvidend21.00Interim Dividend - Rs. - 21.000024 Mar 2023
Bonus
Split

Mutual Fund Holddings